FDA reaches milestone in competitive generic therapy drug approvals

2 September 2021 - This week, the FDA reached the milestone of approving more than 100 generic drug applications with a ...

Read more →

Natco Pharma (Canada) announces the launch of Nat-Lenalidomide capsules, the first generic alternative to Revlimid

1 September 2021 - Nat-Lenalidomide expands affordable treatment options for patients with multiple myeloma and patients with transfusion-dependent anaemia due to ...

Read more →

'New regulation limiting generic drugs will change industrial paradigm'

27 July 2021 - The Korea Pharmaceutical and Bio-pharma Manufacturers Association said the revision of the Pharmaceutical Affairs Act to ...

Read more →

TGA approves first generic pomalidomide

23 June 2021 - The TGA has approved first generic version of Celgene's Pomalyst. ...

Read more →

Acrux receives approval from the FDA for its generic version of Jublia

22 June 2021 - Acrux is pleased to announce that the US FDA has granted approval of the Company’s generic version ...

Read more →

Factors associated with generic drug uptake in the United States, 2012 to 2017

19 June 2021 - In the United States, brand-name prescription drugs remain expensive until market exclusivity ends and lower cost generics ...

Read more →

Lannett announces FDA acceptance, as a priority original ANDA, of the generic Advair Diskus filing

1 June 2021 - Lannett  today announced the U.S. FDA has accepted the abbreviated new drug application for fluticasone propionate and ...

Read more →

Apotex medicines in New Zealand

31 May 2021 - Apotex has announced that it is leaving the New Zealand market. ...

Read more →

7 out of 10 Koreans want cheaper drug with same ingredient

27 May 2021 - Seven out of 10 Koreans want to lower the drug cost by choosing a cheaper generic ...

Read more →

PHARMAC to work with others to improve communication

21 May 2021 - PHARMAC accepts the Coroner’s comments that not all information about the brand change reached patients. ...

Read more →

The TGA claims Tenofovir Emtricitabine Sandoz is a first generic but is it?

22 April 2021 - Closer examination suggests otherwise. ...

Read more →

Oakrum Pharma and Aucta Pharma announce U.S. FDA approval of generic version of Jadenu Sprinkle (deferasirox granules)

22 March 2021 - Oakrum Pharma in collaboration with Aucta Pharmaceuticals announced today the U.S. approval of a generic version of ...

Read more →

Washington may become the second state to distribute its own generic drugs

17 March 2021 - A bill moving through the Washington legislature may make the state only the second in the ...

Read more →

PHARMAC’s drug switch

17 March 2021 - PHARMAC's generic drug swap for epilepsy treatment saved $30 million over five years. But for some ...

Read more →

Sun Pharma announces Drizalma Sprinkle (duloxetine delayed release capsules) is now covered by most Medicare Part D plans

9 March 2021 - Coverage for novel formulation of duloxetine now offered to 91% of lives in top 10 Medicare Part ...

Read more →